Disease-Modifying Jab for Multiple Sclerosis to Be Offered by NHS

Multiple sclerosis (MS) patients will be offered a new 10-minute injection which is said to slow the progression of the disease while cutting treatment time in hospital by over 90 percent, NHS England announced on Friday. Around 9,000 patients in England currently receive the drug ocrelizumab via an infusion that can take four hours, but will now be offered a jab that takes just 10 minutes, following approval from the Medicines and Healthcare products Regulatory Agency (MHRA). Ocrelizumab, manufactured by Swiss pharmaceutical giants Roche under the brand name Ocrevus, is usually given via twice-yearly via intravenous infusions, which can take up to four hours, but patients will now be able to receive the drug via a twice-yearly injection....